Arrow Capital Pty Ltd Makes New Investment in DaVita Inc. (NYSE:DVA)

Arrow Capital Pty Ltd acquired a new stake in DaVita Inc. (NYSE:DVA - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm acquired 10,000 shares of the company's stock, valued at approximately $1,496,000.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of DVA. MML Investors Services LLC lifted its stake in shares of DaVita by 1.3% in the 3rd quarter. MML Investors Services LLC now owns 5,300 shares of the company's stock valued at $869,000 after acquiring an additional 68 shares during the last quarter. M&T Bank Corp grew its holdings in shares of DaVita by 4.2% during the third quarter. M&T Bank Corp now owns 3,534 shares of the company's stock worth $579,000 after purchasing an additional 143 shares during the last quarter. Te Ahumairangi Investment Management Ltd boosted its position in DaVita by 1.0% during the 3rd quarter. Te Ahumairangi Investment Management Ltd now owns 48,137 shares of the company's stock worth $7,846,000 after buying an additional 500 shares during the period. Tidal Investments LLC grew its holdings in DaVita by 45.2% during the 3rd quarter. Tidal Investments LLC now owns 5,688 shares of the company's stock worth $932,000 after acquiring an additional 1,771 shares during the last quarter. Finally, Franklin Resources Inc. raised its stake in shares of DaVita by 134.6% during the third quarter. Franklin Resources Inc. now owns 54,901 shares of the company's stock valued at $8,885,000 after acquiring an additional 31,502 shares during the last quarter. Institutional investors own 90.12% of the company's stock.

DaVita Stock Performance

Shares of NYSE DVA traded up $0.96 during midday trading on Tuesday, hitting $134.46. The company's stock had a trading volume of 301,596 shares, compared to its average volume of 834,079. The stock has a fifty day moving average price of $148.36 and a 200 day moving average price of $155.79. The company has a current ratio of 1.26, a quick ratio of 1.21 and a debt-to-equity ratio of 23.18. DaVita Inc. has a one year low of $128.69 and a one year high of $179.60. The firm has a market capitalization of $10.76 billion, a price-to-earnings ratio of 12.53, a P/E/G ratio of 1.07 and a beta of 1.04.

DaVita (NYSE:DVA - Get Free Report) last posted its earnings results on Thursday, February 13th. The company reported $2.24 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.14 by $0.10. DaVita had a net margin of 7.31% and a return on equity of 115.48%. On average, research analysts forecast that DaVita Inc. will post 10.76 EPS for the current fiscal year.

Analysts Set New Price Targets

DVA has been the subject of a number of recent research reports. StockNews.com upgraded DaVita from a "hold" rating to a "buy" rating in a report on Thursday, April 10th. Barclays lifted their price objective on DaVita from $164.00 to $169.00 and gave the stock an "equal weight" rating in a research note on Tuesday, February 18th. Cowen restated a "hold" rating on shares of DaVita in a report on Tuesday, February 18th. Finally, Sanford C. Bernstein set a $184.00 price target on DaVita in a report on Friday, February 21st. One investment analyst has rated the stock with a sell rating, four have given a hold rating and two have given a buy rating to the stock. According to data from MarketBeat.com, DaVita presently has an average rating of "Hold" and an average price target of $166.33.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.